We are live on ! Find out more
FIA

FNY Investment Advisers Portfolio holdings

AUM $278M
1-Year Est. Return 98.99%
This Fund
S&P 500
This Quarter Est. Return
+1.12%
1 Year Est. Return
+98.99%
3 Year Est. Return
+307.32%
5 Year Est. Return
+396.61%
10 Year Est. Return
AUM
$327M
AUM Growth
-$12.2M
Cap. Flow
-$9.88M
Cap. Flow %
-3.02%
Top 10 Hldgs %
48.42%
Holding
1,378
New
400
Increased
269
Reduced
149
Closed
483

Sector Composition

Rank Sector Weight
1 Healthcare 30.14%
2 Financials 12.64%
3 Industrials 9.02%
4 Consumer Discretionary 7.86%
5 Technology 6.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MICR
201
DELISTED
Micron Solutions, Inc.
MICR
$164K 0.05%
75,051
-23,104
-24% -$55.1K
MRKR icon
202
Marker Therapeutics
MRKR
$19.2M
$163K 0.05%
3,206
+718
+29% +$42.4K
AMRB
203
DELISTED
American River Bankshares
AMRB
$162K 0.05%
+11,946
New +$156K
DDOG icon
204
Datadog
DDOG
$93.6B
$161K 0.05%
+4,750
New +$165K
GHY
205
PGIM Global High Yield Fund
GHY
$479M
$160K 0.05%
11,171
+7,838
+235% +$113K
SABA
206
Saba Capital Income & Opportunities Fund II
SABA
$223M
$160K 0.05%
+13,104
New +$164K
IVH
207
DELISTED
Delaware Ivy High Income Opportunities Fund
IVH
$160K 0.05%
11,680
+4,280
+58% +$58.2K
EVV
208
Eaton Vance Limited Duration Income Fund
EVV
$1.07B
$158K 0.05%
12,655
+10,855
+603% +$136K
FAX
209
abrdn Asia-Pacific Income Fund
FAX
$604M
$157K 0.05%
6,252
-1,740
-22% -$43.8K
OKTA icon
210
Okta
OKTA
$26.2B
$157K 0.05%
+1,600
New +$200K
CROX icon
211
Crocs
CROX
$6.63B
$154K 0.05%
+5,554
New +$135K
SRPT icon
212
Sarepta Therapeutics
SRPT
$1.81B
$154K 0.05%
2,055
-1,723
-46% -$203K
BA icon
213
Boeing
BA
$184B
$152K 0.05%
400
-400
-50% -$143K
RPAYW
214
DELISTED
Repay Holdings Corporation Warrant expiring 07/11/2024
RPAYW
$152K 0.05%
+172,754
New +$121K
CEO
215
DELISTED
CNOOC Limited
CEO
$152K 0.05%
+1,000
New +$157K
HOME
216
DELISTED
At Home Group Inc.
HOME
$151K 0.05%
15,754
+9,611
+156% +$65.6K
QID icon
217
ProShares UltraShort QQQ
QID
$249M
$150K 0.05%
+250
New +$151K
CCIF
218
Carlyle Credit Income Fund
CCIF
$58.3M
$149K 0.05%
14,039
-9,829
-41% -$101K
EMD
219
Western Asset Emerging Markets Debt Fund
EMD
$611M
$149K 0.05%
10,743
+10,095
+1,558% +$142K
IHTA
220
DELISTED
Invesco High Income 2024 Target Term Fund
IHTA
$149K 0.05%
14,400
+1,429
+11% +$14.7K
AKTS
221
DELISTED
Akoustis Technologies Inc
AKTS
$148K 0.05%
19,150
-183,807
-91% -$1.21M
VYX icon
222
NCR Voyix
VYX
$1.09B
$146K 0.04%
+7,581
New +$146K
FSD
223
DELISTED
FIRST TRUST HIGH INCOME LONG/SHORT FUND
FSD
$146K 0.04%
+9,657
New +$144K
DMO
224
Western Asset Mortgage Opportunity Fund
DMO
$120M
$145K 0.04%
6,678
-2,304
-26% -$49.9K
DSL
225
DoubleLine Income Solutions Fund
DSL
$1.23B
$145K 0.04%
+7,300
New +$146K

Similar funds

FNY Investment Advisers's Q3 2019 Portfolio in Review

As of Q3 2019, FNY Investment Advisers held 1,378 positions worth $327M, down 3.6% from $339M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

FNY Investment Advisers withdrew a net $9.88M in Q3 2019, closing 483 positions and reducing 149 holdings. Its most notable exit was Anadarko Petroleum, an estimated $49M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 17% a quarter earlier, followed by Financials and Industrials.

Against the trend, FNY Investment Advisers opened a new position in Genesee & Wyoming Inc. worth $7.43M.

  • FNY Investment Advisers's largest Q3 2019 buy was Genesee & Wyoming Inc.: 67,241 shares worth $7.43M.
  • FNY Investment Advisers added most to Allergan plc in Q3 2019, an estimated $19M increase.
  • FNY Investment Advisers's biggest Q3 2019 reduction was Mellanox Technologies, Ltd., cutting an estimated $4.11M.
  • FNY Investment Advisers fully exited Anadarko Petroleum in Q3 2019, selling an estimated $49M.
  • FNY Investment Advisers's ten largest holdings make up 48% of its $327M portfolio in Q3 2019.
  • FNY Investment Advisers opened 400 new positions and closed 483 in Q3 2019.
  • FNY Investment Advisers's portfolio value fell 3.6% quarter-over-quarter to $327M.

Based on FNY Investment Advisers's 13F filing for Q3 2019, filed 25 Oct 2019.